Strong full year from animal pharma company Dechra
Global veterinary pharmaceuticals company Dechra Pharmaceuticals (DPH) released full year numbers ahead of analysts' forecasts, injecting renewed momentum in the shares, up 1.3% to £30.42.A combination of organic and acquisitive...
02 September 2019